Israeli business Journal Globes recently reported 2020 to be a record-breaking year for Israeli companies raising capital on the New York and Tel Aviv Stock Exchanges.

Since the beginning of
Continue Reading Over US $8 Billion Raised by Israeli Companies in 2020 on Public Markets

Greenberg Traurig is extremely proud to represent Redhill Biopharma with the recent announcement of providing an initial update on the compassionate use program with its investigational drug, opaganib, in patients
Continue Reading Greenberg Traurig Is Proud to Represent Redhill Biopharma Treating COVID-19 Patient with Opaganib in Israel Under Compassionate Use